Notices to Interested Parties : Bureau of Financial Institutions

Department of Professional and Financial Regulation

State of Maine

NOTICE TO INTERESTED PARTIES

This is to inform you that we have received an application, pursuant to 9-B, MRSA Chapter 121, for a certificate of public convenience and advantage to establish a nondepository trust company to be known as Watch Point Trust Company, LLC and to be located at 100 Summer Street, Boston, Massachusetts. The nondepository trust company will have a registered office in Maine.

The application has been filed by Nixon Peabody LLP (“NP”), one of the largest multipractice law firms in the United States. The names, addresses and occupations of the proposed initial directors are listed below.

Deborah L. Anderson              Boston, MA.                           Attorney, NP
Katherine L. Babson, Jr.         Boston, MA.                           Attorney, NP
John H. Clymer             Boston, MA.                           Attorney, NP
Sarah T. Connolly                     Boston, MA.                           Attorney, NP
Thomas M. Farace                  Boston, MA.                           Attorney, NP
John T. Fitzgerald, Jr.              Boston, MA.                           Attorney, NP
Ronald Garmey                        Boston, MA.                           Attorney, NP
Evelyn V. Moreno                     Boston, MA.                           Attorney, NP

            The public is invited to submit written comments on this application to the Bureau of Financial Institutions, 36 State House Station, Augusta, Maine 04333-0036 or electronically through the Bureau of Financial Institutions’ Web site at http://www.maine.gov/financialinstitutions. A hearing on this application will be held by the Superintendent, as provided in 9-B MRSA Section 252, upon receipt of a bona fide and reasonable request. The Bureau will accept written comments and requests for a hearing through Monday, August 2, 2010. The Superintendent's decision on this application will be based on the decision-making criteria set forth in 9-B MRSA Section 253.

John A. Barr

Deputy Superintendent

Gardiner, Maine

June 28, 2010